A recent study provided strong evidence for an involvement of LTβR signaling in inflammatory processes and carcinogenesis, by demonstrating that the LTβR signaling pathway can initiate inflammation-induced carcinogenesis and affect primary tumorigenesis, as well as control the reemergence of carcinoma in various cancer models through distinct mechanisms (9). The gene discussed is LTBR; the disease is carcinoma.